Cargando…
Treatment‐resistant depression as risk factor for substance use disorders—a nation‐wide register‐based cohort study
BACKGROUND AND AIMS: Treatment‐resistant depression (TRD) is common among patients with major depressive disorder (MDD). MDD may increase the risk for developing substance use disorders (SUD). The aim of this study was to investigate the risk for developing SUD among patients with TRD compared with...
Autores principales: | Brenner, Philip, Brandt, Lena, Li, Gang, DiBernardo, Allitia, Bodén, Robert, Reutfors, Johan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593719/ https://www.ncbi.nlm.nih.gov/pubmed/30938020 http://dx.doi.org/10.1111/add.14596 |
Ejemplares similares
-
Substance use disorders and risk for treatment resistant depression: a population‐based, nested case‐control study
por: Brenner, Philip, et al.
Publicado: (2019) -
A register-based approach to identifying treatment-resistant depression—Comparison with clinical definitions
por: Hägg, David, et al.
Publicado: (2020) -
All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population
por: Li, Gang, et al.
Publicado: (2019) -
Risk and risk factors for disability pension among patients with treatment resistant depression– a matched cohort study
por: Taipale, Heidi, et al.
Publicado: (2020) -
Humanistic outcomes in treatment resistant depression: a secondary analysis of the STAR*D study
por: DiBernardo, Allitia, et al.
Publicado: (2018)